Sanofi cuts research staffers in Boston as reorganization looms: report

Sanofi ($SNY) is cutting more than 30 lab workers in its Boston hub, according to the Boston Globe. Citing staffers, the report notes that the jobs are being axed in groups that were part of the Genzyme organization acquired by Sanofi. The layoffs may presage more cuts as Sanofi is rumored to be readying a company-wide reorganization, which includes cutting hundreds of unfilled job openings in France. Report

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.